A Comparative Analysis of the Utility of Nottingham Prognostic Index and Ki-67 in Selecting ER-positive HER2-negative Patients for Oncotype DX Testing
{{output}}
Background: The Oncotype DX Recurrence Score (RS), Nottingham Prognostic Index (NPI), and Ki-67 are commonly used tools to assess recurrence risk and guide adjuvant treatment decisions in early breast cancer. This study evaluated... ...
